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Abstract
Background: Phyllodes tumors are uncommon tumors of the breast that exhibit aggressive growth. While surgical
management of the tumor has been reported, a single surgical approach with immediate breast reconstruction
using AlloDerm has not been reported.
Case presentation: A 22-year-old woman presented with a 4 cm mass in the left breast upon initial examination.
Although the initial needle biopsy report indicated a fibroadenoma, the final pathologic report revealed a 6.5 cm ×
6.4 cm × 6.4 cm benign phyllodes tumor ex vivo. Treatment was a simple nipple-sparing mastectomy coupled with
immediate breast reconstruction. After the mastectomy, a subpectoral pocket was created for a saline implant and
AlloDerm was stitched to the pectoralis and serratus muscle in the lower-pole of the breast.
Conclusions: Saline implant with AlloDerm can be used for immediate breast reconstruction post-mastectomy for
treatment of a phyllodes tumor.
Background
Cystosarcoma phyllodes was first described in 1838 by
Johannes Müller but was not found to be malignant
until 1943 by Cooper and Ackerman [1]. It is now com-
monly called phyllodes tumor. It is less than 1% of
breast tumors and exhibits unpredictable behaviour.
Reports in literature have been focused on surgical
approaches to the tumor removal. Although patient
assessment prior to tumor removal often includes plans
for immediate breast reconstruction, these approaches
are rarely reported unless the tumor is classified as giant
or is in an adolescent female [2-5]. Usual tumor treat-
ment is wide local excision and simple mastectomy
[6-8]. However, there have been few reports on breast
reconstruction with phyllodes tumors, especially within
the last 10 years. Because of the fast growth rate of
these tumors, a greater than a 1 cm negative margin is
preferred with tumor removal and a mastectomy may
have to be performed to prevent local reoccurrence.
Breast reconstruction usually consists of a transverse
rectus abdominis musculocutaneous (TRAM) flap or a
latissimus dorsi (LD) musculocutaneous flap as in other
breast cancers.
Here we report a single surgery that includes recon-
struction of the breast immediately post-mastectomy
using a saline implant and AlloDerm. AlloDerm is
becoming increasingly popular for immediate breast
reconstruction. It is a viable option for athletic or thin
women for whom TRAM or LD is not possible. A sub-
muscular pocket can be created for a breast implant and
AlloDerm is used to give lower-pole fullness. It helps fill
the breast flap when subcutaneous tissue is limited and
supports the breast implant which can have issues such
as rippling or bottoming out [9,10].
Case presentation
The patient was a 22-year-old African American female
who presented with a left breast mass. The mass had
been present for at least 3 months. The left breast was
larger and leaked a clear fluid. Upon initial examination,
the patient’s primary care provider observed a 4 cm
mass. The patient also experienced pain down the left
arm which was reported about a week after the initial
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breast cancer at 39. She had no past medical or surgical
history, did not use tobacco, and menarche occurred at
11 years of age.
Ultrasound of the left breast (Figure 1) revealed a 9
cm × 9 cm × 4.5 cm hypoechoic mass centered at the
12-1 o’clock area. The anterior of the mass appeared to
be within 1 cm of the skin and the posterior was on the
pectoral muscle. The echotexture varied from hypoe-
choic to isoechoic and there are small cystic areas
within the mass. There were no other masses identified
in the left breast or the left axilla. The mass was deemed
suspicious for malignancy and the assessment was Bi-
RADS 4b. The patient was sent for surgical consultation.
Upon surgical consultation a core needle biopsy was
performed with a 22-gauge needle; four biopsies were
obtained. The biopsies were consistent with a fibroade-
noma, indicating a benign tumor, which was consistent
with the presentation of most cystosarcomas in core
needle biopsies [11,12].
The patient underwent a simple mastectomy with
immediate breast reconstruction. Because the tumor
volume was approximately two thirds of the breast and
lumpectomy would result in poor cosmetic outcome,
simple mastectomy with nipple-areola complex (NAC)
preservation was performed on the patient. Standard
breast reconstruction usually consists of a transverse
rectus abdominis musculocutaneous flap or a latissimus
dorsi musculocutaneous flap. However, the patient did
not have adequate fatty tissue at the abdomen for the
TRAM procedure and the patient did not want the large
scar across the abdomen that would result. The plastic
surgeon thought LD was the better choice because it
would provide a “living” breast but this still required a
small implant. The patient opted for a saline implant
with AlloDerm to the mastectomy site and a mastopexy
(breast lift) or mastopexy and implant to the other
breast for symmetry. Because breast reconstruction was
coupled with mastectomy using AlloDerm, there was no
need for a TRAM or LD surgery which reduced scarring
and the patient’s overall recovery time.
The simple mastectomy consisted of an incision along
the mammary crease. Dissection of the breast was car-
ried out by cutting down the anterior pectoral fascia
and dissecting to approximately 1 cm from the clavicle.
Medial dissection was carried out to the left lateral bor-
der of the sternum and lateral dissection was carried
over to the anterior border of the latissimus dorsi mus-
cle. A bovie electrocautery was used to create a superior
flap of the entire left breast.
Next, breast reconstruction was performed. At the
level of the inframammary fold, the pectoralis muscle
was divided from 4 to 8 o’clock and a subpectoral/sub-
serratus pocket was made using an electrocautery. At
the mastectomy site, the superior pole of the breast flap
was thicker than the inferior pole. Therefore, the super-
ior breast tissue was laterally divided and sutured under
the skin and to the pectoralis muscle with 3-0 Mono-
cryl. This smoothed out the contour of the superior
pole. AlloDerm, used to give more lateral fill, was
sutured to the inframammary fold and to the part of the
pectoralis muscle with 3-0 polydioxanone. The saline
implant was then inserted into the pocket. The flap was
advanced down, sutured into place, and the implant was
filled. A drain was inserted and the incision was closed
with Monocryl and Dermabond. For symmetry, the
other breast underwent vertical mastopexy and posi-
tioned by making the superior border of the areola at
the same level as the other breast.
Grossly, the excised encapsulated mass measured 6.5
cm × 6.4 cm × 6.4 cm. The surface was tan with a
whorled appearance. Pathologic findings were consistent
with a benign phyllodes tumor displaying large leaf-like
projections surrounded by uniform stroma (Figure 2a
and 2b) and black-inked margins of resection were
negative (Figure 3).
There were no postoperative complications and hospital
stay was 24 hrs. The patient is currently 41 months post-
surgery and has not had local reoccurrence. The patient is
Figure 1 Ultrasound of benign phyllodes tumor in left breast.
Figure 2 A. Image of leaf-like cystic ducts projected into the
stroma. B. Image of one cystic duct.
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feels that immediate reconstruction was helpful in redu-
cing emotional distress from the diagnosis and surgery.
Discussion
Phyllodes tumor is a disease of the epithelial and stroma
tissue in the breast. It is classified as benign, borderline,
and malignant. Malignant tumors have high stroma cel-
lularity and tend to be permeative whereas benign
tumors have low stroma cellularity and are circum-
scribed [6,7,13,14]. Borderline tumors cannot be distin-
guished between the two because of the uncertainty of
their behavior. These tumors can be encapsulated and
their size typically ranges from 1-45 cm [6]. These
tumors, when discovered, are usually large from their
aggressive growth rate and at beginning stages, cause
virtually no pain or other symptoms [15]. Larger tumors
can result in nipple discharge, deformity of the skin,
pain from the tumor weight, or pain from the impact
on nerves [8,15]. There is no correlation between size
and tumor malignancy [7,16].
Treatment for the disease usually involves wide local
excision with negative margins greater than 1 cm [6-8].
If there is poor tumor to breast size, simple mastectomy
is recommended. There have been a few cases reported
of benign tumors metastizing but this is very rare [7].
These tumors tend not to metastasize to the axillary
lymph nodes but more commonly to bone, lungs, and
liver [6-8]. Adjuvant radiotherapy and chemotherapy
generally are not used because the benefit of these
therapies is unclear [6,7,17]. However, if the margins are
less than 1 cm and there is chest wall invasion, adjuvant
radiotherapy should be strongly considered [6].
As discussed in this report, breast reconstruction can
be performed immediately after tumor removal.
Although immediate breast reconstruction is oncologi-
cally safe to perform after mastectomy [9], Mortenson
and co-workers found wound healing complications
increased from 8.3% to 22.2% [18]. In three breast recon-
struction groups, the tissue expander/implant, TRAM,
and LD group, the site complications were 11.5%, 33%,
and 83% within their own group, respectively.
In breast reconstruction, the NAC is preserved, if possi-
ble, for the best cosmetic outcome. It is still controversial
Figure 3 Negative margin of resection for the benign
phyllodes tumor.
Figure 4 A. Preoperative view of phyllodes tumor in left breast. B. Postoperative view after 4 years with nipple-sparing mastectomy.
Crenshaw et al. World Journal of Surgical Oncology 2011, 9:34
http://www.wjso.com/content/9/1/34
Page 3 of 5to preserve the NAC when the tumor is cancerous and
centrally located because it is unclear if the NAC is
involved with breast cancer [19]. If removed, the NAC can
be reconstructed. Common techniques to reconstruct the
NAC are skin graft and tattoo but it is difficult to obtain
nipple symmetry and reconstructed nipples often have
poor nipple projection, color match, shape, and texture
[19].
There are four main incisions for nipple-sparing mas-
tectomy. The superior or inferior periareolar with lateral
extension, transareolar with perinipple and lateral-med-
ial extension, transareolar and transnipple incision with
medial and lateral extension, and mammary crease that
is inferior or lateral. The superior or inferior periareolar
with lateral extension allows good exposure for tumor
removal but may compromise blood supply to the per-
iphery of the flap and areola [19,20]. The transareolar
with perinipple and lateral-medial extension also pro-
vides good exposure and reduces the risk of ischemia to
the lower portion of the areola. However, care must be
taken not to divide the perinipple artery from the breast
parenchyma causing perinipple scaring resulting in
downward nipple projection [19,20]. The transareolar
and transnipple incision with medial and lateral exten-
sion provides good exposure to the lactiferous ducts for
dissection and good vascularity to the areola and nipple,
but the apical portion of the nipple may still suffer form
ischemia or necrosis [20]. The mammary crease
approach, inferior, was used here. The scar is the least
visible and the skin flap vascularization is supported by
superior and medial vessels [19,20]. Vascularization of
the nipple and areolar are not disturbed with this inci-
sion [20]. This incision is best for smaller breast with
low ptosis as it may be difficult to reach parasternal and
subclavicular areas of the breast for tumor removal. All
incisions have equal risk of necrosis but women under
45 years of age had a higher rate of NAC viability [21].
Since immediate breast reconstruction is being used
with increasing frequency, more surgical approaches are
needed for fast recovery. AlloDerm is an acelluar dermal
matrix from human cadaver skin. The skin has no cellu-
lar components and, for this reason, rejection is not an
issue [9]. The use of AlloDerm in breast reconstruction
has many advantages. It can be used off the shelf which
reduces operation time [9]. If there is not enough sub-
cutaneous tissue to fill a skin flap, AlloDerm can be
used to fill out the inferior pole of the breast. AlloDerm
also helps visually to reduce rippling, stark contours,
and bottoming out seen with larger implants [9,10]. It
also shortens recovery time. Hospital stay for AlloDerm/
implant breast reconstruction was found to be an aver-
a g eo f4 8h o u r s[ 2 2 ] .I ti ss a f et ou s ea n dp r o v i d e s
another option for immediate breast reconstruction.
Conclusions
Management of phyllodes tumors has many challenges
which need to be addressed on a case by case basis. In
this case, a simple mastectomy was the best option for a
young patient with a comparatively large tumor mass.
Although LD with an implant was thought to be the
best choice for breast reconstruction, the patient opted
for just a saline implant with AlloDerm and mastopexy
for symmetry. The cosmetic outcome was good. There-
fore implant reconstruction with AlloDerm should also
be considered along with LD and TRAM if the patient
wants minimal scarring and reduced recovery time.
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